Opportunity ID: 301634

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-18-022
Funding Opportunity Title: Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 14, 2018
Last Updated Date:
Original Closing Date for Applications: Aug 21, 2020
Current Closing Date for Applications: Aug 21, 2020
Archive Date: Sep 26, 2020
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Native American tribal governments (Federally recognized)
Independent school districts
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Small businesses
For profit organizations other than small businesses
City or township governments
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA supports highly innovative R01 applications on HIV/AIDS and drug abuse and complements the Avant-Garde Award Program for HIV/AIDS and Drug Use Research and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS. The Avant-Garde award supports individuals who conduct high-risk, high-reward research and does not require a detailed research plan. The Avenir award is similar to the Avant-Garde award but focuses on support for early stage investigators. Applications submitted under this FOA are required to have a detailed research plan and preliminary data. This FOA focuses on innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among substance abusers. The nexus with drug abuse should be clearly described. This FOA is open to both individual researchers and research teams and is not limited to any one area of research on HIV and substance use, but all studies must focus on NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-022.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00239178 Jul 22, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259267 Jul 22, 2018 Aug 21, 2020 View

Package 1

Mandatory forms

301634 RR_SF424_2_0-2.0.pdf

301634 PHS398_CoverPageSupplement_4_0-4.0.pdf

301634 RR_OtherProjectInfo_1_4-1.4.pdf

301634 PerformanceSite_2_0-2.0.pdf

301634 RR_KeyPersonExpanded_2_0-2.0.pdf

301634 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

301634 RR_Budget_1_4-1.4.pdf

301634 RR_SubawardBudget30_1_4-1.4.pdf

301634 PHS398_ModularBudget_1_2-1.2.pdf

301634 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

301634 RR_SF424_2_0-2.0.pdf

301634 PHS398_CoverPageSupplement_5_0-5.0.pdf

301634 RR_OtherProjectInfo_1_4-1.4.pdf

301634 PerformanceSite_2_0-2.0.pdf

301634 RR_KeyPersonExpanded_2_0-2.0.pdf

301634 PHS398_ResearchPlan_4_0-4.0.pdf

301634 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

301634 RR_Budget_1_4-1.4.pdf

301634 RR_SubawardBudget30_1_4-1.4.pdf

301634 PHS398_ModularBudget_1_2-1.2.pdf

301634 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T11:23:16-05:00

Share This Post, Choose Your Platform!

About the Author: